These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 32499160)
21. Pharmacists' perspectives about their role in care of patients with diabetes observing Ramadan. Almansour HA; Chaar B; Saini B Res Social Adm Pharm; 2017; 13(1):109-122. PubMed ID: 27053428 [TBL] [Abstract][Full Text] [Related]
22. From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmacies. Murphy AL; Martin-Misener R; Kutcher SP; O'Reilly CL; Chen TF; Gardner DM BMC Health Serv Res; 2016 Oct; 16(1):569. PubMed ID: 27729051 [TBL] [Abstract][Full Text] [Related]
23. Delegation: a solution to the workload problem? Observations and interviews with community pharmacists in England. Lea VM; Corlett SA; Rodgers RM Int J Pharm Pract; 2016 May; 24(3):170-9. PubMed ID: 26670719 [TBL] [Abstract][Full Text] [Related]
24. Pharmacists' perceptions and communication of risk for alertness impairing medications. Jomaa I; Odisho M; Cheung JMY; Wong K; Ellis JG; Smyth T; Saini B Res Social Adm Pharm; 2018 Jan; 14(1):31-45. PubMed ID: 28118967 [TBL] [Abstract][Full Text] [Related]
25. Lived experiences and resilience of hospital pharmacists during the COVID-19 pandemic: An interpretative phenomenological analysis. Flotildes MJ; Garcia G; Piol AM; Simeon ENJ; Miranda KJ; Carandang RR Explor Res Clin Soc Pharm; 2023 Sep; 11():100299. PubMed ID: 37521019 [TBL] [Abstract][Full Text] [Related]
26. Towards the implementation of breastfeeding-related health services in community pharmacies: Pharmacists' perspectives. Sim TF; Hattingh HL; Sherriff J; Tee LBG Res Social Adm Pharm; 2017; 13(5):980-988. PubMed ID: 28325528 [TBL] [Abstract][Full Text] [Related]
27. A qualitative study exploring community pharmacists' awareness of, and contribution to, self-care support in the management of long-term conditions in the United Kingdom. Ogunbayo OJ; Schafheutle EI; Cutts C; Noyce PR Res Social Adm Pharm; 2015; 11(6):859-79. PubMed ID: 25677228 [TBL] [Abstract][Full Text] [Related]
28. Community pharmacists' experience and perceptions of the New Medicines Service (NMS). Lucas B; Blenkinsopp A Int J Pharm Pract; 2015 Dec; 23(6):399-406. PubMed ID: 25712253 [TBL] [Abstract][Full Text] [Related]
29. Community pharmacist's professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists. Giua C; Paoletti G; Minerba L; Malipiero G; Melone G; Heffler E; Pistone A; Keber E; Int J Clin Pharm; 2021 Jun; 43(3):708-715. PubMed ID: 33449247 [TBL] [Abstract][Full Text] [Related]
30. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation. Wells KM; Thornley T; Boyd MJ; Boardman HF Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701 [TBL] [Abstract][Full Text] [Related]
31. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS. Blake KB; Madhavan SS Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254 [TBL] [Abstract][Full Text] [Related]
32. Qualitative insights into job satisfaction and dissatisfaction with management among community and hospital pharmacists. Ferguson J; Ashcroft D; Hassell K Res Social Adm Pharm; 2011 Sep; 7(3):306-16. PubMed ID: 21454135 [TBL] [Abstract][Full Text] [Related]
33. Drive-thru pharmacy services: A way forward to combat COVID-19 pandemic. Hussain R; Dawoud DM; Babar ZU Res Social Adm Pharm; 2021 Jan; 17(1):1920-1924. PubMed ID: 32792322 [TBL] [Abstract][Full Text] [Related]
34. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease. Puspitasari HP; Aslani P; Krass I Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140 [TBL] [Abstract][Full Text] [Related]
35. Funding for change: New Zealand pharmacists' views on, and experiences of, the community pharmacy services agreement. Kinsey H; Scahill S; Bye L; Harrison J Int J Pharm Pract; 2016 Dec; 24(6):379-389. PubMed ID: 27121985 [TBL] [Abstract][Full Text] [Related]
36. Pharmacists' experiences and attitudes regarding generic drugs and generic substitution: two sides of the coin. Olsson E; Kälvemark Sporrong S Int J Pharm Pract; 2012 Dec; 20(6):377-83. PubMed ID: 23134096 [TBL] [Abstract][Full Text] [Related]
37. The future of pharmacy practice research - Perspectives of academics and practitioners from Australia, NZ, United Kingdom, Canada and USA. Babar ZU; Scahill S; Nagaria RA; Curley LE Res Social Adm Pharm; 2018 Dec; 14(12):1163-1171. PubMed ID: 29358030 [TBL] [Abstract][Full Text] [Related]
38. On the frontline against COVID-19: Community pharmacists' contribution during a public health crisis. Cadogan CA; Hughes CM Res Social Adm Pharm; 2021 Jan; 17(1):2032-2035. PubMed ID: 32245691 [TBL] [Abstract][Full Text] [Related]
39. Competence, competition and collaboration: Perceived challenges among Swedish community pharmacists engaging in pharmaceutical services provision and research. Frisk P; Holtendal C; Bastholm-Rahmner P; Sporrong SK Int J Pharm Pract; 2019 Aug; 27(4):346-354. PubMed ID: 30707481 [TBL] [Abstract][Full Text] [Related]
40. What role could community pharmacists in Malaysia play in diabetes self-management education and support? The views of individuals with type 2 diabetes. Lee EL; Wong PS; Tan MY; Sheridan J Int J Pharm Pract; 2018 Apr; 26(2):138-147. PubMed ID: 28574154 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]